Meriam Kabbaj
Chief Tech/Sci/R&D Officer chez GENFIT
Profil
Meriam Kabbaj has founded Versantis AG in 2015, where she holds the title of Chief Operating Officer & Director.
She is currently the Chief Technology Officer at Genfit SA since 2022.
Dr. Kabbaj has a doctorate degree from the University of Montréal.
Postes actifs de Meriam Kabbaj
Sociétés | Poste | Début |
---|---|---|
GENFIT | Chief Tech/Sci/R&D Officer | 01/12/2022 |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Founder | 01/01/2015 |
Formation de Meriam Kabbaj
University of Montréal | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
GENFIT | Health Technology |
Entreprise privées | 1 |
---|---|
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Health Technology |